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Periventricular leukomalacia, specifically characterized as white matter injury, in neonates is strongly
associated with the damage of pre-myelinating oligodendrocytes. Clinical data suggest that hypoxia-
ischemia during delivery and intrauterine or neonatal infection-inflammation are important factors in the
etiology of periventricular leukomalacia including cerebral palsy, a serious case exhibiting neurobehavioral
deficits of periventricular leukomalacia. In order to explore the pathophysiological mechanisms of white
matter injury and to better understand how infectious agents may affect the vulnerability of the immature
brain to injury, novel animal models have been developed using hypoperfusion, microbes or bacterial
products (lipopolysaccharide) and excitotoxins. Such efforts have developed rat models that produce
predominantly white matter lesions by adopting combined hypoxia-ischemia technique on postnatal days
1-7, in which unilateral or bilateral carotid arteries of animals are occluded (ischemia) followed by 1-2
hour exposure to 6-8% oxygen environment (hypoxia). Furthermore, low doses of lipopolysaccharide that
by themselves have no adverse-effects in 7-day-old rats, dramatically increase brain injury to hypoxic-
ischemic challenge, implying that inflammation sensitizes the immature central nervous system.
Therefore, among numerous models of periventricular leukomalacia, combination of hypoxia-ischemia-
lipopolysaccharide might be one of the most-acceptable rodent models to induce extensive white matter
injury and ensuing neurobehavioral deficits for the evaluation of candidate therapeutics.
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Cerebral palsy (CP), one of the most-devastating neural
diseases, results from asphyxia during delivery as well as
intrauterine infection [1]. The disease is also called periventricular
leukomalacia (PVL), hypoxia-ischemia encephalopathy (HIE),
white matter injury/damage (WMI/WMD), and CP in serious
cases exhibiting neurobehavioral symptoms. Although asphyxia
during delivery is considered an important etiological factor
in many cases with PVL, the etiology might be multi-factorial.
Infections and inflammation, coagulopathy and genetic
background alone or in combination seem to be important
[2]. Furthermore, it is well known that respiratory dysfunction
is a predominant factor in pre-term infants in which a very-
high incidence of CP is produced [3-6]. Motor, perceptual,
visual, behavioral and/or cognitive disorders occur in the
majority of cases with PVL [7-9]. For a better understanding
of the underlying mechanisms of WMI, several animal models
of PVL have been developed based on the hypoxia-ischemia
(HI) surgery, infection or lipopolysaccharide (LPS) administration,
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or excitotoxin challenge. In this review, we summarized these
models of PVL and analyzed the association between infection/
inflammation and cerebral palsy found in human infants [10].
Neuropathology of Infantile PVL
Although infantile WMI was named PVL [11], it seems
like that WMI is widespread including periventricular,
subcortical and callosal white matters, and internal capsule
[12-15]. Injury of white matter usually predominates, however
gray matter areas, such as the cerebral cortex, thalamus and
basal ganglia, are also affected directly or secondarily due
to loss of white matter according to the severity [14,16]. WMI
lesions are shown to be focal or diffuse [17]. The focal lesions
involve necrosis of all tissue constituents, neurons or axons,
astrocytes and oligodendrocytes, which may lead to cavitary
lesions with surrounding proliferating astrocytes (so called
astrocytosis or hypertrophic astrocytes). In comparison, the
diffuse type involves a broad paucity of white matter, thinning
of the corpus callosum, and often ventriculomegaly in late
stages [18]. Particularly, the diffuse injury is characterized by
astrogliosis, loss of oligodendroglial lineage, and impaired
myelinogenesis [19]. WMI usually occurs during delivery when
the white matter is non-myelinated or in the initial phase
of myelination, and populated mainly by late oligodendroglial
progenitors (O4
+O1
−), but with a small proportion of immature
oligondendroglia (O4
+O1
+) [20]. Axons may also be lost in
the lesions as demonstrated by axonal retraction balls and
clubs [11,21]. Accumulation of amyloid precursor proteins
(APP) [22] and axonal transections [21] are seen in the focal
lesions [23]. In addition to hypertrophic (activated) astrocytes,
microglia and macrophages are also constituents of WMI
[14,15,22], and these cells are immunoreactive for the pro-
inflammatory cytokines including tumor-necrosis factor-α
(TNF-α) and interleukin-6 (IL-6) [24], suggestive of an inflammatory
response. These cells may be reactivated residents of the
white matter or recruited from the blood, indicating the
possible participation of blood-derived inflammatory cells [25].
Etiology of Infantile PVL
There are two major etiologies of PVL; i.e., ischemia
(hypoxia)-reperfusion [26] and infection/inflammation, resulting
in fetal inflammatory responses [27]. The ischemia-reperfusion
process is confirmed by the presence of arterial end and
border zones in the periventricular white matter [28,29],
pressure-passive circulation without autoregulatory function
[30], and the susceptibility of O4
+O1
− late oligodendroglial
progenitors which are predominating oligodendroglial cells
at gestational weeks 24-32 (GW24-32) or GW24-40 susceptible
to oxidative stress, excitotoxicity and in vitro ischemia (Figure
1) [19,20,31-35]. On the other hand, inflammatory pathway
is supported by the fact that WMI is predicted by histological
chorioamnionitis and vasculitis in umbilical cord and chorion
plate as well as pro-inflammatory cytokines such as IL-6 and
IL-8 in amniotic fluid and fetal blood [27,36,37]. In addition,
microglia/macrophages in white matter lesions exhibit
immunoreactivity for IL-6 and TNF-α [24]. Premyelinating
oligodendrocytes (pre-OLs), which have been shown to be
a key cellular target in PVL, are in a phase of active development
during GW24-40 [20,33-35]. Four developmental stages of
oligodendroglial maturation include (1) oligodendroglial
progenitors, (2) late oligodendroglial progenitors (O4
+O1
− pre-
oligodendrocytes), (3) immature oligodendrocytes (O4
+O1
+),
Figure 1. Developmental stage-dependent periventricular leukomalacia of rodents induced by hypoxia-ischemia. PND, post-natal
day; WMI, white matter injury.Animal models of periventricular leukomalacia 79
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and (4) mature myelin-producing oligodendrocytes [myelin
basic protein (MBP) positive (MBP
+)]. Pre-oligodendrocytes
(late oligodendroglial progenitors) and immature oligodendrocytes
are referred as pre-OLs. These differentiating forms, especially
the O4
+O1
+ immature oligodendrocytes, ensheath axons for
differentiation into myelin-producing oligodendrocytes.
Mature, MBP-expressing and ultimately myelin-producing
oligodendrocytes are not abundant in cerebral white matter
until after term. During the peak period of PVL, O4
+O1
−
late oligodendroglial progenitors predominate in cerebral white
matter and at GW28 account for 90% of the total
oligodendroglial population [20]. At GW28-40, O4
+O1
− cells
begin differentiation into O4
+O1
+ immature oligodendrocytes,
which consists of approximately 30% of total oligodendrocyte
population during the later premature period and about 50%
by term. These two early differentiating cells are specifically
vulnerable to injurious insults, such as ischemia and
inflammation, which lead to excitotoxicity and generation
of free radicals. These pre-OLs show enhanced vulnerability
to the following factors: (1) reactive oxygen species (ROS)
and reactive nitrogen species (RNS), because of impaired
antioxidant defenses; (2) excitotoxicity due to exuberant
expression of calcium-permeable glutamate receptors, and
enhanced expression of the main glutamate transporter, which
can become a source of injurious glutamate; and (3) cytokine
injury, because of both expression of the interferon-γ (IFN-
ã) receptors on the pre-OLs in the context of pronounced
availability of IFN-γ in the abundant astrocytes of PVL, and
sensitivity to injury by tumor-necrosis factor-α (TNF-α), which
is secreted by the abundant activated microglia [38-52].
Microglia play key roles during brain development, involving
apoptosis, vascularization, axonal development, and myelination
[53-56]. Thus, microglia become prominent in the forebrain
at GW16-22 [57-60], reaching a peak in cerebral white matter
in the third trimester [60]. It is believed that microglia be
key effectors of cellular injury following ischemia and/or
inflammation, since they generate ROS/RNS, secrete injurious
cytokines, and enhance excitotoxicity [44-48,58,61-63].
Because microglia are abundant in normal cerebral white
matter during peri-natal period, their activation leads to injury
to white matter constituents including pre-OLs, and also axons
and subplate neurons [60]. Not surprisingly, it was found out
that many activated microglia are present diffusely in cerebral
white matter in association with pre-OLs injury in PVL [39].
Animal Models of PVL
According to clinical information described above, a large
number of animal models of PVL have been developed. PVL
can be induced either by induction of a systemic inflammatory
response through administration of bacteria or its products
such as LPS [64-69], or ante- or post-natal HI surgery [68,70-
73]. White matter lesions can also be induced by N-methyl-
D-aspartate (NMDA) [65,74] and non-NMDA receptor [68]
agonists, indicating that excitotoxicity may be involved in
the development of PVL. The period prior to generalized
myelinogenesis represents the developmental stage with a
high vulnerability of white matter [19,65,73,75-78]. The white
matter vulnerability has been related to the presence of
O4
+O1
− pre-OLs at GW24-32 in humans [19,20,73]. The
pre-OLs (O4
+O1
−) are susceptible to HI in immature rats,
whereas O4
+O1
+ immature oligodendrocytes are not [73].
Oligodendrocytes immunoreactive for O4 but negative for
O1 predominate in the rat white matter on post-natal days
2-4 (PND2-4) [68,73], whereas O4
+O1
+ cells predominate
on PND7. This agrees with the suggestion in mice [65] that
PND5 corresponds to GW24-30 in humans with regard to
white matter maturation [77]. These studies suggest that white
matter vulnerability in the rat/mouse on PND4, rather than
PND7, would correspond to the white matter vulnerability
in pre-term infants.
Hypoperfusion models
In most of the HI models of PVL, both gray and white
matters are affected, except for the dog model of ischemia
[79] or hemorrhagic hypotension model [71] in fetal sheep,
which produced selective WMI. In general, the pattern of
WMI in rabbits, cats, dogs and sheep has a distribution and
morphological features closer to human pre-term brain lesions
(predominantly white matter) than that in rodents (Table 1)
[1]. Induction of extensive WMI is difficult in rats and mice,
which may be due to the different central nervous system
(CNS) anatomy of rodents that have a much lower white/
gray matter ratio. However, based on the cost efficiency,
availability of antibodies and transgenic animals, rodent PVL
models are acceptable. Earlier, a PVL model in immature
animals with unilateral carotid ligation and exposure to 8%
oxygen environment for 1-3 hours was introduced [80], in
Table 1. Comparative time schedule for CNS development in
animals and humans [1]






Rabbit GD20-28 (70-85%) Birth, GD33 (100%)
Dog Birth PNW>2
Sheep GD93-99 GD119-133 (90%)
PND, post-natal day; GD, gestational day; PNW, post-natal week.80 Ehn-Kyoung Choi et al.
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which even though the vulnerability of myelinogenic zones
was emphasized, most researches in this model have focused
on gray matter injury. Nevertheless, it has been used successfully
to study the response of immature oligodendroglial and stem/
progenitor cells in white matter and periventricular zones
to HI both in 9-day-old mice [81] and 7-day-old rats [73,82,83].
A corresponding model in 1-day-old rats has also been
developed, which produces injury predominantly in the gray
matter [84]. Recently, a modification model in rats, unilateral
carotid artery ligation and 6% oxygen for 1 hour on PND7,
was found to lead to selective loss of O1
+ oligodendroglia
and decrease of MBP in the corpus callosum and periventricular
white matter 4 days later, without affecting gray matter [68].
Another study induced a loss of O4
+ cells in the corpus
callosum by bilateral carotid artery ligation and 10-min
exposure to 8% oxygen environment [70]. In another study,
permanent bilateral carotid artery ligation of PND5 or PND7
rats resulted in subcortical white and gray matter injuries
[72,83]. However, because of limited survival beyond 2-3
days [83], 2-hour transient bilateral carotid ligation allowed
long-term survival and still produced similar distribution of
damage in subcortical regions. In comparison, permanent
bilateral carotid artery ligation of 1-day-old rats allowed long-
term survival longer than 2 weeks and produced WMI in
corpus callosum, subcortex, internal capsule, and a significant
enlargement of the ventricles [85] with limited pathology in
the gray matter. Although rodent models need to be further
explored, unilateral carotid artery ligation followed by exposure
8% oxygen for 2-3 hours is suitable, since various parameters
to evaluate neurobehavioral deficits are obtainable, without
mortality [83]. Interestingly, a model was introduced in rabbit
fetuses of gestational days 21-25 (GD21-25), subjected to
intrauterine hypoperfusion and WMI affecting O4
+O1
− pre-
oligodendrocytes, were found 1-7 days after the insult [78].
Post-natal changes in magnetic resonance imaging (MRI) were
found in the white matter and, moreover, severe neurological
dysfunctions were demonstrated after birth approximately 10
days post-induction [86].
Inflammation models
Extra-amniotic or intrauterine inoculation of live E. coli
[67,87,88] without antibiotics induced pre-term stillbirth within
48 hours. In live pups sacrificed at 12-30 hours, brain injury
was not detected [67,88]. However, antibiotic administration
prevented pre-term delivery and fetal infection was delayed.
Brain injury was detected in a part of pups after 2-6 days
[87,88]. It is of interest to note that most fetuses with brain
injury were blood culture negative, whereas there were
inflammatory changes in chorioamniotic membranes. The
results indicate that brain injury is related to the sustained
inflammatory response rather than to passage of microbes
into the brain, which is supported by the lack of massive
accumulation of granulocytes in the CNS lesions [67].
Underlying mechanisms of LPS-induced PVL are not fully
known. LPS is believed to activate innate immune system
via interaction with toll-like receptors (TLR) on immune cells
[89]. LPS binds to CD14 that facilitates activation of TLR-
4, which in turn, resulting in nuclear factor-κB (NF-κB)
activation and production of pro-inflammatory cytokines
[89,90]. Thus, TLR-4- or CD14-deficient mice do not respond
to LPS. TLR-4 receptors were found in the immature brain,
and LPS administration induced an increased expression of
CD14 [69]. In addition to the inflammatory response [91,92],
LPS induces hypoperfusion [93], hypoglycemia [93], hyperthermia
[91] and lactic acidosis, which may important factors triggering
brain damage. In fact, a high dose of LPS (12 mg/kg) induced
hypotension (50% decrease) as well as decrease in cerebral
blood flow (CBF) in white matter, suggesting that hypoperfusion
is an important contributor to injury in this region [93].
Interestingly, even a lower dose of LPS (4 mg/kg), leading
to a 20-30% decrease in arterial blood pressure, was enough
to induce widespread white matter lesions. Therefore, it is
expected that appropriate (moderate) doses of LPS would
induce hypoperfusion and injury of white matter. In young
rabbits, intravenous injection of LPS (10 mg/kg) was found
to decrease CBF by 25 and 43% in cerebral cortex and white
matter, respectively [94]. However, brain injury was seen in
the both regions, making it uncertain to what extent the
decrease of CBF was the critical level for brain injury. Moreover,
it was reported that WMI evolved in response to repeated
doses of LPS in fetal sheep, in spite of the fact that hemodynamic
effects became less pronounced, suggesting that hypoperfusion
was not the critical factor [95]. Thus, it is suggested that the
LPS-induced development of brain injury cannot be fully
explained in terms of cerebral hypoperfusion. Especially, white
or gray matter injuries in rats (PND5-7) were not successfully
produced using various dose levels of LPS (0.3 mg/kg up to
100 mg/kg), in spite of a marked mRNA expression of pro-
inflammatory cytokines in the white matter [66,69,96],
implying that at least this form of CNS inflammation in rats
was not sufficient to produce WMI. Such results indicate
that LPS-induced WMI might be caused by a combination
of systemic and CNS inflammatory effects.
Excitotoxic models
Intracerebral administration of excitatory amino acid (EAA)
receptor agonists [NMDA and DL-α-amino-3-hydroxy-5-
methyl-4-isoxalone propionic acid (AMPA)] in PND7-14 ratsAnimal models of periventricular leukomalacia 81
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has been shown to induce lesions 40 times larger than in
adult rats in the striatum, hippocampus and cerebral cortex
[74]. Subcortical injection of ibotenate (an NMDA receptor
agonist) in PND5 mice produced cortical and white matter
injuries [65,97]. The topographical localization, ontogenetic
window, and pharmacology of the lesions suggested that the
lesions were primary, not secondary to the lesions in cerebral
cortex or other gray matter areas. Indeed, microglia activation
is triggered by NMDA, leading to extensive astroglial (but
not oligodendroglial) death [97]. By comparison, injection
of AMPA to PND7 rats caused selective WMI affecting O4
+O1
+
pre-oligodendroglia (expressing GluR4 receptors), which was
attenuated by NBQX (an AMPA receptor antagonist), but not
by dizocilpine (MK-801; an NMDA receptor antagonist) [68].
Furthermore, in pre-oligodendroglial cultures, EAA-mediated
inhibition of cystine uptake led to the depletion of glutathione
and susceptibility to injury evoked by oxygen free radicals
[31]. In spite of partial contradiction, these studies suggest
that NMDA and AMPA receptors as well as non-receptor-
mediated mechanisms may be involved in WMI. Injection
of high doses of excitotoxins is highly artificial and the role
of excitotoxicity in WMI remains obscure, but such paradigms
may be useful to explain some aspects of human disease.
Comparison of PVL models
In sheep fetuses, both LPS (100 ng) injection and asphyxia
(25-min umbilical cord occlusion) caused periventricular (focal
and diffuse) and subcortical (diffuse) WMI with a quite similar
distribution, except for somewhat broader involvement of
the gray matter (striatum and hippocampus) after umbilical
cord occlusion. In both models, there were acute losses of
glial fibrillary acidic protein (GFAP)-positive astroglia and cyclic
nucleotide phosphohydrolase (CNPase)-positive immature
oligodendroglia. In contrast, marked microglial responses were
seen in both models, although microglial accumulation was
more focal within the lesions induced by LPS. Furthermore,
inflammatory cell infiltrations occurred much more frequently
after LPS challenge, probably corresponding to macrophages/
polymorphonuclear neutrophiles (PMNs) found in other
models of LPS-induced WMI in cats and dogs [91,92] or
after local administration of LPS into the immature brain [98].
The results suggest that PVL evoked by a systemic inflammation
(inflammatory WMI) has a different morphological appearance
than that produced by hypoperfusion (ischemic WMI). And
comparison of the underlying mechanisms of the two lesions
may be of interest as these forms of injury may have clinical
relevance [26,27]. The different distribution of microglia and
macrophages following the two insults may be critical, because
these cells appear to have a key role in ibotenate-induced
WMI [97], and because microglial toxicity depends on the
density of microglia [99].
Only intraperitoneal administration of LPS to the pregnant
rats or to the neonatal pups does not produce consistent
brain injury [66,69]. However, LPS (0.3 mg/kg), intraperitoneally
given 4 hours prior to HI in 7-day-old rats (brain maturity
corresponding to near term), sensitized the brain to injury;
20-min HI plus LPS injection (HIL) induced extensive lesions
in all animals, whereas 20-min HI alone produced essentially
minimal or no injury [69]. In contrast, administration of another
endotoxin, lipoteichoic acid, 3 hours prior to HI reduced
brain injury [100]. Thus, further studies are necessary to find
out whether this intriguing difference can be explained by
the fact that LPS and lipoteichoic acid act via different receptors
[90].
The potential of infections and inflammation in brain injury
is not limited to pre-term infants. The relationship between
infection/inflammation and PVL including CP may be higher
in term rather than in pre-term infants [101,102]. Notably,
chorioamnionitis was related to serious CP with 9-fold higher
risk [10], in which the levels of pro-inflammatory cytokines
and chemokines were much higher [103]. Moreover, the
combination of intrauterine infection and asphyxia during
delivery (hard labor) appeared to confer a synergistic effect
with a substantially (78-fold) higher risk of CP [104], suggesting
that inflammation (or infectious products) may sensitize the
fetus to additional insults.
Conclusion
Earlier, experimental researches on peri-natal brain injury
have focused on hypoxic-ischemic damage to reflect the
clinical problem of birth asphyxia, which has demonstrated
critical clues on the pathophysiology of immature neuronal
injury. However, only a small proportion of casualties suffering
from PVL, especially CP , are related to asphyxia. In our recent
understanding, intrauterine or peri-natal infection is emerged
to be an important factor in pre-term as well as in term
infants. Consequently, a number of novel animal models have
been introduced in various species to demonstrate the features
of WMI and explain underlying pathology in the early
immature brain, either induced by hypoperfusion or infectious
agents. Furthermore, recent studies have shown that bacterial
endotoxin sensitize the brain to a secondary HI, supportive
of the involvement of combinational factors in infantile brain
injury. Conclusively, it is suggested that HIL models that consists
of hypoxia-ischemia-LPS could be one of the best choices
to induce extensive WMI and ensuing neurobehavioral deficits
for the screening of candidate therapeutics.82 Ehn-Kyoung Choi et al.
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